Terms: = Skin cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Prognosis
13 results:
1. Exploring and validating the prognostic value of pathomics signatures and genomics in patients with cutaneous melanoma based on bioinformatics and deep learning.
Li X; Yu X; Tian D; Liu Y; Li D
Med Phys; 2023 Nov; 50(11):7049-7059. PubMed ID: 37722701
[TBL] [Abstract] [Full Text] [Related]
2. KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.
Ito T; Tanaka Y; Ichiki T; Kaku-Ito Y; Nakahara T
Hum Cell; 2023 Sep; 36(5):1813-1829. PubMed ID: 37432591
[TBL] [Abstract] [Full Text] [Related]
3. HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling.
Deng H; Chen Y; Wang J; An R
PLoS One; 2022; 17(9):e0274897. PubMed ID: 36129956
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine.
Ping H; Yu W; Gong X; Tong X; Lin C; Chen Z; Cai C; Guo K; Ke H
Invest New Drugs; 2022 Dec; 40(6):1173-1184. PubMed ID: 35962880
[TBL] [Abstract] [Full Text] [Related]
5. Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
Zhang E; Chen Y; Bao S; Hou X; Hu J; Mu OYN; Song Y; Shan L
Hum Genomics; 2021 Aug; 15(1):53. PubMed ID: 34384498
[TBL] [Abstract] [Full Text] [Related]
6. Interleukin-33 modulates immune responses in cutaneous melanoma in a context-specific way.
Peng L; Sun W; Wei F; Chen L; Wen W
Aging (Albany NY); 2021 Feb; 13(5):6740-6751. PubMed ID: 33621202
[TBL] [Abstract] [Full Text] [Related]
7. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
Qu Y; Zhang S; Zhang Y; Feng X; Wang F
Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
[TBL] [Abstract] [Full Text] [Related]
8. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
[TBL] [Abstract] [Full Text] [Related]
9. Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival.
Vallet A; Oriano B; Mortier L; Dalle S; Dutriaux C; Guillot B; Leccia MT; Dalac S; Saiag P; Lacour JP; Legoupil D; De Quatrebarbes J; Brunet-Possenti F; Lesimple T; Arnault JP; Aubin F; Granel-Brocard F; Stoebner PE; Maubec E; Dreno B; Allayous C; Porcher R; Lebbé C;
JAMA Dermatol; 2019 Jun; 155(6):673-678. PubMed ID: 31042256
[TBL] [Abstract] [Full Text] [Related]
10. Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.
Tiffen J; Wilson S; Gallagher SJ; Hersey P; Filipp FV
Neoplasia; 2016 Feb; 18(2):121-32. PubMed ID: 26936398
[TBL] [Abstract] [Full Text] [Related]
11. Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma.
Horwich A; Fossa SD; Huddart R; Dearnaley DP; Stenning S; Aresu M; Bliss JM; Hall E
Br J Cancer; 2014 Jan; 110(1):256-63. PubMed ID: 24263066
[TBL] [Abstract] [Full Text] [Related]
12. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage.
Paulson KG; Iyer JG; Blom A; Warton EM; Sokil M; Yelistratova L; Schuman L; Nagase K; Bhatia S; Asgari MM; Nghiem P
J Invest Dermatol; 2013 Mar; 133(3):642-646. PubMed ID: 23190897
[TBL] [Abstract] [Full Text] [Related]
13. Langerhans cells and their precursors with S100 protein in mycosis fungoides.
Igisu K; Watanabe S; Shimosato Y; Kukita A
Jpn J Clin Oncol; 1983 Dec; 13(4):693-702. PubMed ID: 6196502
[TBL] [Abstract] [Full Text] [Related]
